Reaction

Pulmonary Vasculitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 522 reports · 79 co-occurring drugs

As of the last recalculation, Pulmonary Vasculitis appears in 522 FAERS reports alongside 79 co-occurring drug terms. The strongest observed disproportionality signal is DUTASTERIDE (PRR 1,012.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Dutasteride	148	1,012.5	1,031.4
Cefuroxime	179	949.6	964.8
Drs. Clotrimazole	174	899.9	913.7
Family Wellness Clotrimazole	174	899.9	913.7
Clotrimazole Topical	174	899.5	913.3
Clotrimazole	174	846.8	859.0
Ciclesonide	153	633.2	640.4
Insulin Glargine-Yfgn	186	526.3	530.9
Cephalexin	170	464.0	467.7
Moxifloxacin	116	421.9	425.4
Moxifloxacin Hydrochloride	148	405.9	408.9
Magnesium Oxide	210	334.2	335.9
Tamsulosin Hydrochloride	128	331.0	333.1
Candesartan	181	309.2	310.8
Sennosides	160	307.4	309.0
Antacid	206	285.0	286.2
Levofloxacin	230	271.1	272.1
Levofloxacin In 5% Dextrose	230	271.1	272.1
Doxazosin Mesylate	157	247.5	248.6
Azithromycin	169	247.1	248.2
Candesartan Cilexetil	122	241.1	242.2
Azithromycin Monohydrate	169	238.7	239.7
Calcium Carbonate	220	225.0	225.8
Doxazosin	120	221.7	222.7
Budesonide	201	220.6	221.3
Mepolizumab	177	214.4	215.2
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	151	204.1	204.8
Azithromycin Dihydrate	189	200.8	201.5
Diltiazem Hydrochloride Extended-Release Tablets	48	185.1	185.9
Umeclidinium Bromide And Vilanterol Trifenatate	65	177.1	177.8
Diltiazem Hydrochloride	115	169.7	170.3
Liraglutide	146	163.2	163.7
Azathioprine	212	160.9	161.3
Trimethoprim	38	138.6	139.0
Bisacodyl Suppositories	41	137.0	137.5
Biscodyl	41	135.8	136.2
Alendronate Sodium	204	131.7	131.9
Bisacodyl	42	129.3	129.7
Albuterol	218	123.6	123.9
Fluticasone Propionate And Salmeterol Xinafoate	137	123.0	123.2
Insulin Aspart	146	121.9	122.1
Escitalopram Oxalate	155	120.1	120.4
Montelukast	162	111.1	111.4
Senna Leaf	53	101.8	102.1
Metformin Hydrochloride Tablets	114	101.1	101.3
Metformin Hydrochloride Extended-Release Tablets	114	101.1	101.3
Metformin Hydrochloride Tablet	114	101.1	101.3
Escitslopram	113	98.6	98.8
Metformin Hydrochloride	114	98.0	98.2
Pantoprazole Sodium In 0.9% Sodium Chloride	112	91.4	91.6
Pantoprazole Sodium Injection	112	91.4	91.6
Salmeterol Xinafoate	19	91.2	91.4
Fluticasone Furoate And Vilanterol Trifenatate	67	85.1	85.2
Mometasone	35	81.5	81.6
Thiamine Hydrochloride	23	77.0	77.2
Rosuvastatin Calcium	46	71.3	71.4
Apixaban	90	64.6	64.7
Levothyroxine Sodium Anhydrous	122	63.1	63.1
Escitalopram	155	62.2	62.3
Tiotropium Bromide	151	61.4	61.5
Sulfamethoxazole And Trimethoprim	102	59.7	59.7
Montelukast Sodium	135	59.3	59.3
Albuterol Sulfate	231	54.9	54.9
Senna	26	51.7	51.8
Amoxicillin And Clavulanate Potassium	32	49.9	50.0
Sennosides 8.6 Mg Tablets	25	49.9	50.0
Hydrochlorothiazide	131	47.7	47.7
Insulin Glargine	189	47.3	47.4
Alendronate Sodium Tablet	20	44.7	44.8
Metformin	226	43.8	43.8
Pantoprazole Sodium	115	39.4	39.4
Fluticasone Furoate	10	33.5	33.6
Sertraline Hydrochloride	84	33.5	33.5
Amoxicillin	57	33.3	33.3
Mometasone Furoate	32	32.6	32.6
Carbamazepine	49	32.1	32.1
Fluticasone Propionate	82	29.7	29.7
Thiotepa	6	25.3	25.3
Pioglitazone	22	21.1	21.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.